More recently, researchers have induced stem cells from
diseased human somatic cells, which may serve as new model systems for various illnesses.
Not exact matches
The survey, described today in a Policy Forum published by Science, randomly presented people with different vignettes that described genome editing being used in germline or
somatic cells to either treat
disease or enhance a
human with, say, a gene linked to higher IQ or eye color.
Human embryonic stem
cells derived from affected embryos during a pre-implantation diagnostic (PGD), as well as the conversion of
somatic cells, such as skin fibroblasts, into induced pluripotent stem
cells by genetic manipulation, offer the unique opportunity to have access to a large spectrum of
disease - specific
cell models.
Disease - specific human pluripotent stem cells, from embryonic origin or derived from reprogramming somatic cells, offer the unique opportunity to have access to a large spectrum of disease - specific cell
Disease - specific
human pluripotent stem
cells, from embryonic origin or derived from reprogramming
somatic cells, offer the unique opportunity to have access to a large spectrum of
disease - specific cell
disease - specific
cell models.
The reprogramming of
human somatic cells into induced pluripotent stem
cells (iPSCs) offers tremendous potential for
cell therapy, basic research,
disease modeling, and drug development.
Reprogramming
human somatic cells to pluripotency represents a valuable resource for the development of in vitro based models for
human disease and holds tremendous potential for deriving patient - specific pluripotent stem
cells.